• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The Role of Salvage Resection After Definitive Radiation Therapy for Non-small Cell Lung Cancer.

作者信息

Rosenstein Allison L, Potter Alexandra L, Senthil Priyanka, Raman Vignesh, Kumar Arvind, Muniappan Ashok, Berry Mark F, Yang Chi-Fu Jeffrey

机构信息

Division of Thoracic Surgery, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts.

Division of Cardiovascular and Thoracic Surgery, Duke University Medical Center, Durham, North Carolina.

出版信息

Ann Thorac Surg. 2023 Nov;116(5):997-1003. doi: 10.1016/j.athoracsur.2023.07.035. Epub 2023 Aug 6.

DOI:10.1016/j.athoracsur.2023.07.035
PMID:37544397
Abstract

BACKGROUND

This study evaluated outcomes of patients who undergo extended delay to resection after definitive radiation therapy for non-small cell lung cancer (NSCLC).

METHODS

Perioperative outcomes and 5-year overall survival of patients with NSCLC who underwent definitive radiation therapy, followed by resection, from 2004 to 2020 in the National Cancer Database were evaluated. Patients who underwent resection >180 days after the initiation of radiation therapy (including any external beam therapy at a total dose of >60 Gy) were included in the analysis. Subgroup analyses were conducted by operation type and pathologic nodal status.

RESULTS

From 2004 to 2020, 293 patients had an extended delay to resection after definitive radiation therapy. The clinical stage distribution was stage I to II in 53 patients (18.1%), stage IIIA in 111 (37.9%), stage IIIB in 106 (36.2%), stage IIIC in 13 (4.4%), and stage IV in 10 (3.4%). Median dose of radiation therapy received was 64.8 Gy (interquartile range, 60.0-66.6 Gy). Median days from radiation therapy to resection were 221.0 (interquartile range, 193.0-287.0) days. Lobectomy (64.5%) was the most common operation, followed by pneumonectomy (17.1%) and wedge resection (7.5%). For wedge resection, lobectomy, and pneumonectomy, the 30-day readmission rate was 4.8%, 4.8%, and 8.3%, the 30-day mortality rate was 0%, 3.4%, and 6.4%, and the 90-day mortality rate was 0%, 6.2%, and 12.8%, respectively. Overall survival at 5 years for patients with pN0, pN1, and pN2 disease was 38.6% (95% CI, 30.0-47.2), 43.3% (95% CI, 16.3-67.9), and 24.0% (95% CI, 9.8-41.7), respectively.

CONCLUSIONS

In this national analysis, extended delay to resection after definitive radiation therapy was associated with acceptable perioperative outcomes among a highly selected patient cohort.

摘要

相似文献

1
The Role of Salvage Resection After Definitive Radiation Therapy for Non-small Cell Lung Cancer.
Ann Thorac Surg. 2023 Nov;116(5):997-1003. doi: 10.1016/j.athoracsur.2023.07.035. Epub 2023 Aug 6.
2
Long-Term Outcomes of Lobectomy for Non-Small Cell Lung Cancer After Definitive Radiation Treatment.根治性放疗后非小细胞肺癌肺叶切除术的长期疗效
Ann Thorac Surg. 2015 Jun;99(6):1914-20. doi: 10.1016/j.athoracsur.2015.01.064. Epub 2015 Apr 15.
3
Feasibility and efficacy of salvage lung resection after definitive chemoradiation therapy for Stage III non-small-cell lung cancer.Ⅲ期非小细胞肺癌根治性放化疗后挽救性肺切除术的可行性和疗效
Interact Cardiovasc Thorac Surg. 2016 Dec;23(6):895-901. doi: 10.1093/icvts/ivw245. Epub 2016 Aug 19.
4
Salvage Lung Resections After Definitive Chemoradiotherapy: A Safe and Effective Oncologic Option.根治性放化疗后挽救性肺切除术:一种安全有效的肿瘤治疗选择。
Ann Thorac Surg. 2020 Oct;110(4):1123-1130. doi: 10.1016/j.athoracsur.2020.04.035. Epub 2020 May 28.
5
Trimodality vs Chemoradiation and Salvage Resection in cN2 Stage IIIA Non-Small Cell Lung Cancer.三模态治疗与放化疗联合挽救性切除术治疗 cN2 期 IIIA 期非小细胞肺癌的对比。
Semin Thorac Cardiovasc Surg. 2020 Spring;32(1):153-159. doi: 10.1053/j.semtcvs.2019.06.002. Epub 2019 Jun 17.
6
Wedge Resection vs Lobectomy for Clinical Stage IA Non-Small Cell Lung Cancer With Occult Lymph Node Disease.楔形切除术与肺叶切除术治疗隐匿性淋巴结疾病的ⅠA 期非小细胞肺癌的比较。
Ann Thorac Surg. 2023 Jun;115(6):1344-1351. doi: 10.1016/j.athoracsur.2022.08.044. Epub 2022 Sep 17.
7
Long-Term Survival after Salvage Surgery for Local Failure after Definitive Chemoradiation Therapy for Locally Advanced Non-small Cell Lung Cancer.局部晚期非小细胞肺癌根治性放化疗后局部复发行挽救性手术后的长期生存情况
Thorac Cardiovasc Surg. 2018 Mar;66(2):135-141. doi: 10.1055/s-0037-1606597. Epub 2017 Oct 9.
8
Salvage surgery after definitive chemo-radiotherapy for patients with Non-Small Cell Lung Cancer.根治性放化疗后非小细胞肺癌患者的挽救性手术。
Lung Cancer. 2019 Jul;133:117-122. doi: 10.1016/j.lungcan.2019.05.010. Epub 2019 May 13.
9
Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.非小细胞肺癌根治性放疗(>59 Gy)及同步化疗后的肺切除术
Ann Thorac Surg. 2004 Oct;78(4):1200-5; discussion 1206. doi: 10.1016/j.athoracsur.2004.04.085.
10
Optimal Surgical Timing After Neoadjuvant Therapy for Stage IIIa Non-Small Cell Lung Cancer.新辅助治疗后 IIIa 期非小细胞肺癌的最佳手术时机。
Ann Thorac Surg. 2020 Mar;109(3):842-847. doi: 10.1016/j.athoracsur.2019.09.076. Epub 2019 Nov 19.

引用本文的文献

1
Surgery for Patients With cT3/4N2M0, Stage IIIB NSCLC. Is It Time to Redefine Resectability?cT3/4N2M0 ⅢB 期非小细胞肺癌患者的手术治疗。是时候重新定义可切除性了吗?
JTO Clin Res Rep. 2024 Nov 14;6(1):100766. doi: 10.1016/j.jtocrr.2024.100766. eCollection 2025 Jan.